Home Markets Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports

Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports

Jun 17, 2025 comments off

Original source: https://www.investing.com/news/stock-market-news/eli-lilly-nears-13-billion-deal-for-geneediting-biotech-verve-therapeutics-ft-reports-4098210

You May Also Like

Putin proposes summit with Trump and Xi on Ukraine- WSJ

Australia’s Cleanaway agrees to $6.5 bln EQT buyout bid; shares surge

Why is Challenger stock surging today?

Anthropic to commit 5% stake to new public benefit fund

Anthropic commits 5% of shares to new public benefit fund

Rubio arrives in Central Asia while other US officials hit foreign policy hot spots